(NASDAQ:DAWN), BRISBANE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare […]
NORWALK, Conn., Nov. 18, 2024 (GLOBE NEWSWIRE) — CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for October 2024. The report, which tracks the issuance of new security identifiers as an early indicator of debt and capital markets activity over the next quarter, found a notable increase in request
Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson’s disease ARISE will evaluate the efficacy of solengepras as an adjunctive therapy to levodopa and other background Parkinson’s disease medications Company expects to report topline data in the first half of 2026 BOSTON, Nov. 18, 2024 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage
(NasdaqGM:NEWT), BOCA RATON, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (NASDAQ: NEWT) announced today that its national bank subsidiary, Newtek Bank, N.A., member FDIC, has launched Newtek Zero-Fee Business Banking(TM), which provides its commercial clients with true zero-fee business banking depository accounts without hidden banking fees or costs. Newtek Bank does not charge
SEATTLE, Nov. 18, 2024 (GLOBE NEWSWIRE) — Nametag Inc., the leading provider of integrated identity verification and account protection solutions, today announced its inclusion in the 2024 Gartner Emerging Tech: Techscape for Startups in Security Software1 report, and in the inaugural 2024 Gartner Magic Quadrant for Identity Verification (IDV). 2 “We're thrilled to be mentioned
Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson's disease ARISE will evaluate the efficacy of solengepras as an adjunctive therapy to levodopa and other background Parkinson's disease medications Company expects to report topline data in the first half of 2026 BOSTON, Nov. 18, 2024 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage
Sacramento, CA , Nov. 18, 2024 (GLOBE NEWSWIRE) — Scharf Inspections, a leading provider of premier home inspection services in Sacramento, CA, is proud to announce the launch of its updated home inspection reports. These new reports feature added pictures and comprehensive how-to information for repairs, enhancing the clarity and usefulness of home inspections for
Sacramento, CA , Nov. 18, 2024 (GLOBE NEWSWIRE) — Scharf Inspections, a leading provider of premier home inspection services in Sacramento, CA, is proud to announce the launch of its updated home inspection reports. These new reports feature added pictures and comprehensive how-to information for repairs, enhancing the clarity and usefulness of home inspections for
Residential Home Health and Hospice, a division of Graham Healthcare Group, is proud to announce that it has been named a 2024 Top Workplace by the Detroit Free Press. This is the 14th year in a row that Residential Home Health and Hospice has received this honor in the Detroit market. https://mma.prnewswire.com/media/1887026/Graham_Healthcare_Group_Logo.jpg The Detroit Free
Residential Home Health and Hospice, a division of Graham Healthcare Group, is proud to announce that it has been named a 2024 Top Workplace by the Detroit Free Press. This is the 14th year in a row that Residential Home Health and Hospice has received this honor in the Detroit market. https://mma.prnewswire.com/media/1887026/Graham_Healthcare_Group_Logo.jpg The Detroit Free